Clinical evidence and real-world remission statistics for treatment-resistant depression.
When antidepressant medications fail to provide adequate relief, patients often wonder: 'What are the real success rates of TMS therapy?' Large-scale clinical trials and real-world psychiatric registries consistently demonstrate that Transcranial Magnetic Stimulation is one of the most effective non-invasive treatments available for major depressive disorder.
In multi-center clinical trials and extensive real-world registry studies, approximately 70% to 83% of patients with treatment-resistant depression experience a significant, measurable clinical response (at least a 50% reduction in depressive symptoms). Furthermore, between 50% and 62% of patients achieve complete symptom remission, meaning they no longer meet the clinical criteria for major depression.
The mood improvements achieved through a full course of TMS therapy are remarkably durable. Research published in major psychiatric journals shows that the vast majority of patients maintain their clinical improvement for 12 months or longer following completion of treatment. If mild symptoms begin to reappear down the road, brief maintenance 'booster' sessions can rapidly restore full therapeutic response.
Reactivates dormant neural circuits in the prefrontal cortex.
Promotes enduring synaptic neuroplasticity without chemical tolerance.
Zero anesthesia, zero memory loss, and no post-session recovery downtime.
Under the direct leadership of Dr. Ritesh Amin, MD, every treatment protocol is individualized to your anatomical mapping and diagnostic history.
Helpful information about TMS therapy, insurance coverage, candidate qualification, and what to expect.
You do not have to struggle in silence with treatment-resistant depression or anxiety. Dr. Ritesh Amin and our dedicated team are ready to help you recover.